HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients

Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,531 · see citing works

Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,526 · see citing works

HDAC6 is a microtubule-associated deacetylase

Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · see citing works

A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,239 · see citing works

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564 · see citing works

State of play in amyotrophic lateral sclerosis genetics

Renton, A. E., Chiò, A., & Traynor, B. J. (2013) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,563 · see citing works

Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man

Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M.-S., Castellano-Sanchez, A. A., Khan, J., Polak, M. A., & Glass, J. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.004 · Cited by 1,338 · see citing works

An ER-Mitochondria Tethering Complex Revealed by a Synthetic Biology Screen

Kornmann, B., Currie, E., Collins, S. R., Schuldiner, M., Nunnari, J., Weissman, J. S., & Walter, P. (2009) · Science · doi:10.1126/science.1175088 · Cited by 1,275 · see citing works

Microtubule Acetylation Promotes Kinesin-1 Binding and Transport

Reed, N. A., Cai, D., Blasius, T. L., Jih, G. T., Meyhofer, E., Gaertig, J., & Verhey, K. J. (2006) · Current Biology · doi:10.1016/j.cub.2006.09.014 · Cited by 919 · see citing works

Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Butler, K. V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., & Kozikowski, A. P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102758v · Cited by 801 · see citing works

Miro1 Is a Calcium Sensor for Glutamate Receptor-Dependent Localization of Mitochondria at Synapses

MacAskill, A. F., Rinholm, J. E., Twelvetrees, A. E., Arancibia‐Cárcamo, I. L., Muir, J., Fransson, Å., Aspenström, P., Attwell, D., & Kittler, J. T. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.030 · Cited by 677 · see citing works

Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons

Wainger, B. J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S. S. W., Sandoe, J., Perez, N. P., Williams, L. A., Lee, S., Boulting, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.019 · Cited by 652 · see citing works

Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons

Williamson, T. L., & Cleveland, D. W. (1999) · Nature Neuroscience · doi:10.1038/4553 · Cited by 638 · see citing works

ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43

Stoica, R., Vos, K. J. D., Paillusson, S., Mueller, S., Sancho, R. M., Lau, K., Vizcay‐Barrena, G., Lin, W.-L., Xu, Y.-F., Lewis, J. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4996 · Cited by 623 · see citing works

Where the endoplasmic reticulum and the mitochondrion tie the knot: The mitochondria-associated membrane (MAM)

Raturi, A., & Simmen, T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.013 · Cited by 448 · see citing works

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

d’Ydewalle, C. V. O., Krishnan, J., Chiheb, D., Damme, P. V., Irobi, J., Kozikowski, A. P., Berghe, P. V., Timmerman, V., Robberecht, W., & Bosch, L. V. D. (2011) · Nature Medicine · doi:10.1038/nm.2396 · Cited by 448 · see citing works

Correction: Corrigendum: Host genetic determinants of microbiota-dependent nutrition revealed by genome-wide analysis of Drosophila melanogaster

Dobson, A. J., Chaston, J. M., Newell, P. D., Donahue, L. R., Hermann, S. L., Sannino, D. R., Westmiller, S., Wong, A. C.-N., Clark, A. G., Lazzaro, B. P., et al. (2015) · Nature Communications · doi:10.1038/ncomms8296 · Cited by 445 · see citing works

Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1

Kiskinis, E., Sandoe, J., Williams, L. A., Boulting, G. L., Moccia, R., Wainger, B. J., Han, S., Peng, T., Thams, S., Mikkilineni, S., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.03.004 · Cited by 441 · see citing works

There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases

Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439 · see citing works

Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes

Maury, Y., Côme, J., Piskorowski, R. A., Salah‐Mohellibi, N., Chevaleyre, V., Peschanski, M., Martinat, C., & Nedelec, S. (2014) · Nature Biotechnology · doi:10.1038/nbt.3049 · Cited by 410 · see citing works

ER sliding dynamics and ER-mitochondrial contacts occur on acetylated microtubules

Friedman, J. R., Webster, B. M., Mastronarde, D. N., Verhey, K. J., & Voeltz, G. K. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911024 · Cited by 393 · see citing works

Control of mitochondrial transport and localization in neurons

MacAskill, A. F., & Kittler, J. T. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.11.002 · Cited by 372 · see citing works

RNA targets of wild-type and mutant FET family proteins

Hoell, J. I., Larsson, E., Runge, S., Nusbaum, J. D., Duggimpudi, S., Farazi, T. A., Hafner, M., Borkhardt, A., Sander, C., & Tuschl, T. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2163 · Cited by 350 · see citing works

ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function

Sharma, A., Lyashchenko, A. K., Lü, L., Nasrabady, S. E., Elmaleh, M., Mendelsohn, M. M., Nemes, A., Tapia, J. C., Mentis, G. Z., & Shneider, N. A. (2016) · Nature Communications · doi:10.1038/ncomms10465 · Cited by 339 · see citing works

Regulated protein aggregation: stress granules and neurodegeneration

Wolozin, B. L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-56 · Cited by 338 · see citing works

Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons

Chen, H., Qian, K., Du, Z., Cao, J., Petersen, A., Liu, H., Blackbourn, L. W., Huang, C.-L., Errigo, A., Yin, Y., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.004 · Cited by 318 · see citing works

Neurofilaments and Orthograde Transport Are Reduced in Ventral Root Axons of Transgenic Mice that Express Human SOD1 with a G93A Mutation

Zhang, B., Tu, P., Abtahian, F., Trojanowski, J. Q., & Lee, V. M. ‐. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1307 · Cited by 299 · see citing works

Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability

Devlin, A., Burr, K., Borooah, S., Foster, J. D., Cleary, E. M., Geti, I., Vallier, L., Shaw, C. E., Chandran, S., & Miles, G. B. (2015) · Nature Communications · doi:10.1038/ncomms6999 · Cited by 295 · see citing works

Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations

Godena, V. K., Brookes-Hocking, N., Möller, A., Shaw, G., Oswald, M. C. W., Sancho, R. M., Miller, C. C. J., Whitworth, A. J., & Vos, K. J. D. (2014) · Nature Communications · doi:10.1038/ncomms6245 · Cited by 279 · see citing works

TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update

Lattante, S., Rouleau, G. A., & Kabashi, E. (2013) · Human Mutation · doi:10.1002/humu.22319 · Cited by 262 · see citing works

ALS/FTD‐associated FUS activates GSK‐3β to disrupt the VAPB–PTPIP51 interaction and ER–mitochondria associations

Stoica, R., Paillusson, S., Gómez‐Suaga, P., Mitchell, J. C., Lau, D. H. W., Gray, E. H., Sancho, R. M., Vizcay‐Barrena, G., Vos, K. J. D., Shaw, C. E., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541726 · Cited by 254 · see citing works

Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?

Vos, K. J. D., & Hafezparast, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.004 · Cited by 238 · see citing works

The role of phospholipids in the biological activity and structure of the endoplasmic reticulum

Lagace, T. A., & Ridgway, N. D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.018 · Cited by 232 · see citing works

Knockdown of transactive response DNA‐binding protein (TDP‐43) downregulates histone deacetylase 6

Fiesel, F. C., Voigt, A., Weber, S. S., den Haute, C. V., Waldenmaier, A., Görner, K., Walter, M. J., Anderson, M. L., Kern, J. V., Rasse, T. M., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.324 · Cited by 226 · see citing works

Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA*

Kim, S. H., Shanware, N. P., Bowler, M. J., & Tibbetts, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154831 · Cited by 213 · see citing works

Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations

Bäumer, D., Hilton, D. A., Paine, S., Turner, M. R., Lowe, J. S., Talbot, K., & Ansorge, O. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ed9cde · Cited by 202 · see citing works

Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients

Liu, M.-L., Zang, T., & Zhang, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.018 · Cited by 156 · see citing works

ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN

Groen, E. J. N., Fumoto, K., Blokhuis, A. M., Engelen-Lee, J.-Y., Zhou, Y., van den Heuvel, D. M. A., Koppers, M., van Diggelen, F., van Heest, J., Demmers, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt222 · Cited by 152 · see citing works

Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen

Schwarze, U., Cundy, T., Pyott, S. M., Christiansen, H. E., Hegde, M., Bank, R. A., Pals, G., Ankala, A., Conneely, K. N., Seaver, L. H., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds371 · Cited by 139 · see citing works

Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS

Taes, I., Timmers, M., Hersmus, N., Bento‐Abreu, A., Bosch, L. V. D., Damme, P. V., Auwerx, J. H., & Robberecht, W. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt028 · Cited by 139 · see citing works

Fused in sarcoma (FUS): An oncogene goes awry in neurodegeneration

Dormann, D., & Haass, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.03.006 · Cited by 134 · see citing works

Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene Inhibition

Ordovás, L., Boon, R., Pistoni, M., Chen, Y., Wolfs, E., Guo, W., Sambathkumar, R., Bobis‐Wozowicz, S., Helsen, N., Vanhove, J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.09.004 · Cited by 132 · see citing works

4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells

Naujock, M., Stanslowsky, N., Bufler, S., Naumann, M., Reinhardt, P., Sterneckert, J. L., Kefalakes, E., Kassebaum, C., Bursch, F., Lojewski, X., et al. (2016) · Stem Cells · doi:10.1002/stem.2354 · Cited by 125 · see citing works

Axonal transport defects are a common phenotype in Drosophila models of ALS

Baldwin, K. R., Godena, V. K., Hewitt, V. L., & Whitworth, A. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw105 · Cited by 105 · see citing works

Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells

Ichiyanagi, N., Fujimori, K., Yano, M., Ishihara-Fujisaki, C., Sone, T., Akiyama, T., Okada, Y., Akamatsu, W., Matsumoto, T., Ishikawa, M., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.011 · Cited by 93 · see citing works

Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization

Wang, W., Arakawa, H., Wang, L., Okolo, O. B., Siedlak, S. L., Jiang, Y., Gao, J., Xie, F., Petersen, R. B., & Wang, X. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.013 · Cited by 90 · see citing works

The dynein inhibitor C iliobrevin D inhibits the bidirectional transport of organelles along sensory axons and impairs NGF‐mediated regulation of growth cones and axon branches

Sainath, R., & Gallo, G. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22246 · Cited by 78 · see citing works

FUS-related proteinopathies: Lessons from animal models

Lanson, N. A., & Pandey, U. B. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.039 · Cited by 64 · see citing works

Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY‐738) recovers Alzheimer's disease phenotype in amyloid precursor protein/presenilin 1 (APP/PS1) mice

Majid, T., Griffin, D. M., Criss, Z. K., Jarpe, M. B., & Pautler, R. G. (2015) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2015.08.001 · Cited by 60 · see citing works

Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)

Poppe, L., Rué, L., Robberecht, W., & Bosch, L. V. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.001 · Cited by 50 · see citing works

HDAC6 Is a Bruchpilot Deacetylase that Facilitates Neurotransmitter Release

Miśkiewicz, K., Jose, L. E., Yeshaw, W. M., Valadas, J. S., Swerts, J., Munck, S., Feiguin, F. M., Dermaut, B., & Verstreken, P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.051 · Cited by 44 · see citing works

Investigating CNS synaptogenesis at single-synapse resolution by combining reverse genetics with correlative light and electron microscopy

Urwyler, O., Izadifar, A., Dascenco, D., Petrovic, M., He, H., Ayaz, D., Kremer, A., Lippens, S., Baatsen, P., Guérin, C. J., et al. (2014) · Development · doi:10.1242/dev.115071 · Cited by 40 · see citing works

Modeling motor neuron disease: the matter of time

Arbab, M., Baars, S., & Geijsen, N. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.008 · Cited by 33 · see citing works

The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation

Liu, X., Chen, J., Liu, W., Li, X., Chen, Q., Liu, T., Gao, S., & Deng, M. (2015) · Neurogenetics · doi:10.1007/s10048-015-0448-y · Cited by 32 · see citing works

Characteristics of intermittent mitochondrial transport in guinea pig enteric nerve fibers

Berghe, P. V., Hennig, G. W., & Smith, T. K. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00283.2003 · Cited by 30 · see citing works

Modelling FUSopathies: focus on protein aggregation

Shelkovnikova, T. A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130212 · Cited by 17 · see citing works

Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus

Ordovás, L., Boon, R., Pistoni, M., Chen, Y., Sambathkumar, R., Helsen, N., Vanhove, J., Berckmans, P., Cai, Q., Vanuytsel, K., et al. (2016) · Journal of Visualized Experiments · doi:10.3791/54718 · Cited by 3 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

The tubulin code and its role in controlling microtubule properties and functions

Janke, C., & Magiera, M. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0214-3 · Cited by 956 · see citing works

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01310 · Cited by 799 · see citing works

Genome-Wide Analyses Identify KIF5A as a Novel ALS Gene

Nicolas, A., Kenna, K. P., Renton, A. E., Ticozzi, N., Faghri, F., Chia, R., Dominov, J. A., Kenna, B., Nalls, M. A., Keagle, P. J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.02.027 · Cited by 670 · see citing works

Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects

Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet‐Nocca, C., Tsvetkov, P. O., Devred, F., & Landrieu, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00204 · Cited by 653 · see citing works

Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation

Mead, R. J., Shan, N., Reiser, H. J., Marshall, F., & Shaw, P. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00612-2 · Cited by 505 · see citing works

Axonal transport and neurological disease

Sleigh, J. N., Rossor, A. M., Fellows, A. D., Tosolini, A. P., & Schiavo, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0257-2 · Cited by 318 · see citing works

Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions

Nussbacher, J. K., Tabet, R., Yeo, G. W.-M., & Lagier‐Tourenne, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.014 · Cited by 264 · see citing works

Energy metabolism in ALS: an underappreciated opportunity?

Vandoorne, T., Bock, K. D., & Bosch, L. V. D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1835-x · Cited by 260 · see citing works

ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS

López‐Erauskin, J., Tadokoro, T., Baughn, M. W., Myers, B., McAlonis‐Downes, M., Chillón-Marinas, C., Asiaban, J. N., Artates, J. W., Bui, A. T., Vetto, A. P., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.044 · Cited by 233 · see citing works

Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective

Kumar, V., Kundu, S., Singh, A., & Singh, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666210609160017 · Cited by 210 · see citing works

Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis

Wang, H., Guo, W., Mitra, J., Hegde, P. M., Vandoorne, T., Eckelmann, B. J., Mitra, S., Tomkinson, A. E., Van Den Bosch, L., & Hegde, M. L. (2018) · Nature Communications · doi:10.1038/s41467-018-06111-6 · Cited by 205 · see citing works

Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications

Guo, W., Dittlau, K. S., & Bosch, L. V. D. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.010 · Cited by 186 · see citing works

RNA toxicity in non‐coding repeat expansion disorders

Swinnen, B., Robberecht, W., & Bosch, L. V. D. (2019) · The EMBO Journal · doi:10.15252/embj.2018101112 · Cited by 161 · see citing works

Disrupted neuronal trafficking in amyotrophic lateral sclerosis

Burk, K., & Pasterkamp, R. J. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01964-7 · Cited by 162 · see citing works

Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases

Carey, J. L., & Guo, L. E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.826719 · Cited by 158 · see citing works

Current State and Future Directions in the Therapy of ALS

Tzeplaeff, L., Wilfling, S., Requardt, M. V., & Herdick, M. L. (2023) · Cells · doi:10.3390/cells12111523 · Cited by 150 · see citing works

The key role of solvent in condensation: Mapping water in liquid-liquid phase-separated FUS

Ahlers, J., Adams, E. M., Bader, V., Pezzotti, S., Winklhofer, K. F., Tatzelt, J., & Havenith, M. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.01.019 · Cited by 139 · see citing works

Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening

Chang, C.-Y., Ting, H.-C., Liu, C.-A., Su, H., Chiou, T., Lin, S., Harn, H., & Ho, T. (2020) · Molecules · doi:10.3390/molecules25082000 · Cited by 133 · see citing works

Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy

Suzuki, N., Nishiyama, A., Warita, H., & Aoki, M. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01055-8 · Cited by 143 · see citing works

Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease

Bennett, S. A., Tanaz, R., Cobos, S. N., & Torrente, M. P. (2018) · Translational research · doi:10.1016/j.trsl.2018.10.002 · Cited by 132 · see citing works

Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases

Teixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.01.005 · Cited by 132 · see citing works

Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis

Mehta, A. R., Gregory, J. M., Dando, O., Carter, R. N., Burr, K., Nanda, J., Story, D., McDade, K., Smith, C., Morton, N. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02252-5 · Cited by 122 · see citing works

Disruption of axonal transport in neurodegeneration

Berth, S. H., & Lloyd, T. E. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168554 · Cited by 126 · see citing works

C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels

Beckers, J., Tharkeshwar, A. K., & Damme, P. V. (2021) · Autophagy · doi:10.1080/15548627.2021.1872189 · Cited by 132 · see citing works

Mutant C9orf72 human iPSC‐derived astrocytes cause non‐cell autonomous motor neuron pathophysiology

Zhao, C. N., Devlin, A., Chouhan, A. K., Selvaraj, B. T., Stavrou, M., Burr, K., Brivio, V., He, X., Mehta, A. R., Story, D., et al. (2019) · Glia · doi:10.1002/glia.23761 · Cited by 123 · see citing works

Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition

Kalinski, A. L., Kar, A. N., Craver, J., Tosolini, A. P., Sleigh, J. N., Lee, S. J., Hawthorne, A. L., Brito‐Vargas, P., Miller-Randolph, S., Passino, R., et al. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201702187 · Cited by 119 · see citing works

HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

Benoy, V., Helleputte, L. V., Prior, R. C., d’Ydewalle, C. V. O., Haeck, W., Geens, N., Scheveneels, W., Schevenels, B., Cader, M. Z., Talbot, K., et al. (2017) · Brain · doi:10.1093/brain/awx375 · Cited by 116 · see citing works

Thermodynamic forces from protein and water govern condensate formation of an intrinsically disordered protein domain

(2023) · doi:10.1038/s41467-023-41586-y · Cited by 118 · see citing works

Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target

Lechner, S., Malgapo, M. I. P., Grätz, C., Steimbach, R. R., Baron, A., Rüther, P. L., Nadal, S., Stumpf, C., Loos, C., Ku, X., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01015-5 · Cited by 114 · see citing works

Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy

Mo, Z., Zhao, X., Liu, H., Hu, Q., Chen, X., Pham, J., Wei, N., Liu, Z., Zhou, J., Burgess, R. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03461-z · Cited by 111 · see citing works

Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering

Tribble, J. R., Hui, F., Quintero, H., Hajji, S. E., Bell, K. C., Polo, A. D., & Williams, P. A. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101193 · Cited by 115 · see citing works

HDAC6 inhibition restores TDP‐43 pathology and axonal transport defects in human motor neurons with TARDBP mutations

Fazal, R., Boeynaems, S., Swijsen, A., De Decker, M., Fumagalli, L., Moisse, M., Vanneste, J., Guo, W., Boon, R., Vercruysse, T., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106177 · Cited by 108 · see citing works

Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ mouse

Genin, E. C., Hounoum, B. M., Bannwarth, S., Fragaki, K., Lacas‐Gervais, S., Mauri-Crouzet, A., Lespinasse, F., Neveu, J., Ropert, B., Augé, G., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01988-z · Cited by 109 · see citing works

Aggregation of the nucleic acid–binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation

Chen, Y., & Cohen, T. J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006351 · Cited by 100 · see citing works

HDAC6 in Diseases of Cognition and of Neurons

LoPresti, P. (2020) · Cells · doi:10.3390/cells10010012 · Cited by 105 · see citing works

An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline

Trzeciakiewicz, H., Ajit, D., Tseng, J.-H., Chen, Y., Ajit, A., Tabassum, Z., Lobrovich, R., Peterson, C., Riddick, N. V., Itano, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19317-4 · Cited by 102 · see citing works

Tubulin post‐translational modifications control neuronal development and functions

Moutin, M., Bosc, C., Peris, L., & Andrieux, A. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22774 · Cited by 97 · see citing works

Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation

Giacomelli, E., Vahsen, B. F., Calder, E. L., Xu, Y., Scaber, J., Gray, E., Dafinca, R., Talbot, K., & Studer, L. (2022) · Cell stem cell · doi:10.1016/j.stem.2021.12.008 · Cited by 97 · see citing works

A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)

Shen, S., & Kozikowski, A. P. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1708901 · Cited by 95 · see citing works

Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies

Pomeshchik, Y., Klementieva, O., Gil, J., Martinsson, I., Hansen, M. G., de Vries, T., Sancho-Balsells, A., Russ, K., Savchenko, E., Collin, A., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.06.001 · Cited by 95 · see citing works

How Does Chirality Determine the Selective Inhibition of Histone Deacetylase 6? A Lesson from Trichostatin A Enantiomers Based on Molecular Dynamics

Zhang, Y., Ying, J. B., Hong, J. J., Li, F., Fu, T. T., Yang, F. Y., Zheng, G. X., Yao, X., Lou, Y., Qiu, Y., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00729 · Cited by 94 · see citing works

C9orf72 -derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility

Fumagalli, L., Young, F. L., Boeynaems, S., Decker, M. D., Mehta, A. R., Swijsen, A., Fazal, R., Guo, W., Moisse, M., Beckers, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3013 · Cited by 89 · see citing works

Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model

Rossaert, E., Pollari, E., Jaspers, T., Van Helleputte, L., Jarpe, M., Van Damme, P., De Bock, K., Moisse, M., & Van Den Bosch, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0750-2 · Cited by 93 · see citing works

Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes

Sleigh, J. N., Tosolini, A. P., Gordon, D., Devoy, A., Fratta, P., Fisher, E., Talbot, K., & Schiavo, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.078 · Cited by 93 · see citing works

Importance of Functional Loss of FUS in FTLD/ALS

Ishigaki, S., & Sobue, G. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00044 · Cited by 88 · see citing works

Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor

Shen, S., Svoboda, M., Zhang, G., Cavasin, M. A., Motlova, L., McKinsey, T. A., Eubanks, J. H., Bařinka, C., & Kozikowski, A. P. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00560 · Cited by 87 · see citing works

The Acetylation of Lysine-376 of G3BP1 Regulates RNA Binding and Stress Granule Dynamics

Gál, J., Chen, J., Na, D.-Y., Tichacek, L., Barnett, K. R., & Zhu, H. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00052-19 · Cited by 86 · see citing works

Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis

Ling, S., Dastidar, S. G., Tokunaga, S., Ho, W. Y., Lim, K., Ilieva, H. S., Parone, P. A., Tyan, S.-H., Tse, T. M., Chang, J., et al. (2019) · eLife · doi:10.7554/elife.40811 · Cited by 81 · see citing works

Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition

Dittlau, K. S., Krasnow, E. N., Fumagalli, L., Vandoorne, T., Baatsen, P., Kerstens, A., Giacomazzi, G., Pavie, B., Rossaert, E., Beckers, J., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.029 · Cited by 85 · see citing works

Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis

Jutzi, D., Campagne, S., Schmidt, R., Reber, S., Mechtersheimer, J., Gypas, F., Schweingruber, C., Colombo, M., von Schroetter, C., Loughlin, F. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20191-3 · Cited by 83 · see citing works

Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective

Kodavati, M. M., Wang, H., & Hegde, M. L. (2020) · Cells · doi:10.3390/cells9041065 · Cited by 87 · see citing works

Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs

Hawrot, J., Imhof, S., & Wainger, B. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104680 · Cited by 74 · see citing works

Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis

Wang, G., Rayner, S. L., Chung, R. S., Shi, B., & Liang, X. J. (2020) · Materials Today Bio · doi:10.1016/j.mtbio.2020.100055 · Cited by 81 · see citing works

Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome

Kozikowski, A. P., Shen, S., Pardo, M., Tavares, M. T., Szarics, D., Benoy, V., Zimprich, C., Kutil, Z., Zhang, G., Bařinka, C., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00600 · Cited by 80 · see citing works

Gene Therapy in Amyotrophic Lateral Sclerosis

Fang, T., Je, G., Pacut, P., Keyhanian, K., Gao, J., & Ghasemi, M. (2022) · Cells · doi:10.3390/cells11132066 · Cited by 82 · see citing works

The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain

Ronowska, A., Szutowicz, A., Bielarczyk, H., Gul‐Hinc, S., Klimaszewska‐Łata, J., Dyś, A., Zyśk, M., & Jankowska-Kulawy, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00169 · Cited by 76 · see citing works

The role of altered protein acetylation in neurodegenerative disease

Kabir, F., Atkinson, R., Cook, A. L., Phipps, A. J., & King, A. E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1025473 · Cited by 75 · see citing works

The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity

Provenzano, F., Torazza, C., Bonifacino, T., Bonanno, G., & Milanese, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015430 · Cited by 74 · see citing works

Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders

Jablonka, S., Hennlein, L., & Sendtner, M. (2022) · Neurological Research and Practice · doi:10.1186/s42466-021-00162-9 · Cited by 73 · see citing works

Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Kirola, L., Mukherjee, A., & Mutsuddi, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02934-z · Cited by 71 · see citing works

FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms

Dittlau, K. S., Terrie, L., Baatsen, P., Kerstens, A., Swert, L. D., Janky, R., Corthout, N., Masrori, P., Damme, P. V., Hyttel, P., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00591-3 · Cited by 69 · see citing works

Aberrant Axon Branching Via Fos-B Dysregulation in FUS-ALS Motor Neurons

Akiyama, T., Suzuki, N., Ishikawa, M., Fujimori, K., Sone, T., Kawada, J., Funayama, R., Fujishima, F., Mitsuzawa, S., Ikeda, K., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.013 · Cited by 70 · see citing works

Towards Advanced iPSC-based Drug Development for Neurodegenerative Disease

Pasteuning-Vuhman, S., de Jongh, R., Timmers, A., & Pasterkamp, R. J. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.013 · Cited by 71 · see citing works

Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 bodies

Haidar, M., Asselbergh, B., Adriaenssens, E., Winter, V. D., Timmermans, J., Auer‐Grumbach, M., Juneja, M., & Timmerman, V. (2019) · Autophagy · doi:10.1080/15548627.2019.1569930 · Cited by 70 · see citing works

C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport

Vanneste, J., Vercruysse, T., Boeynaems, S., Sicart, A., Damme, P. V., Daelemans, D., & Bosch, L. V. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-52035-6 · Cited by 68 · see citing works

Lost in local translation: TDP-43 and FUS in axonal/neuromuscular junction maintenance and dysregulation in amyotrophic lateral sclerosis

Piol, D., Robberechts, T., & Cruz, S. D. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.028 · Cited by 68 · see citing works

Microtubule acetylation dyshomeostasis in Parkinson’s disease

Naren, P., Khan, S. S., Tryphena, K. P., Vora, L. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00354-0 · Cited by 63 · see citing works

CRISPR/Cas9-Mediated Gene Correction to Understand ALS

Yun, Y., & Ha, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113801 · Cited by 64 · see citing works

HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice

Picci, C., Wong, V. S. C., Costa, C. J., McKinnon, M. C., Goldberg, D. C., Swift, M. L., Alam, N. M., Prusky, G. T., Shen, S., Kozikowski, A. P., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113281 · Cited by 63 · see citing works

Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications

Moens, T. G., Cruz, S. D., Neumann, M., Shelkovnikova, T. A., Shneider, N. A., & Bosch, L. V. D. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00517-9 · Cited by 63 · see citing works

Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells

Guo, W., Fumagalli, L., Prior, R. C., & Bosch, L. V. D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00671 · Cited by 59 · see citing works

HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo

Sanna, S., Esposito, S., Masala, A., Sini, P., Nieddu, G., Galioto, M., Fais, M., Iaccarino, C., Cestra, G., & Crosio, C. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2580-3 · Cited by 61 · see citing works

Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction

Lent, J. V., Verstraelen, P., Asselbergh, B., Adriaenssens, E., Mateiu, L. M., Verbist, C., Winter, V. D., Eggermont, K., Bosch, L. V. D., Vos, W. H. D., et al. (2021) · Brain · doi:10.1093/brain/awab226 · Cited by 60 · see citing works

Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons

Sainio, M. T., Rasila, T. S., Molchanova, S. M., Järvilehto, J., Torregrosa‐Muñumer, R., Harjuhaahto, S., Pennonen, J., Huber, N., Herukka, S., Haapasalo, A., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.820105 · Cited by 59 · see citing works

Aggresome formation and liquid–liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43

Watanabe, S., Inami, H., Oiwa, K., Murata, Y., Sakai, S., Komine, O., Sobue, A., Iguchi, Y., Katsuno, M., & Yamanaka, K. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03116-2 · Cited by 60 · see citing works

A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice

Onishi, T., Maeda, R., Terada, M., Sato, S., Fujii, T., Ito, M., Hashikami, K., Kawamoto, T., & Tanaka, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94923-w · Cited by 59 · see citing works

ALS and FTD: Where RNA metabolism meets protein quality control

Mandrioli, J., Mediani, L., Alberti, S., & Carra, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.06.003 · Cited by 57 · see citing works

Differentiation but not ALS mutations in FUS rewires motor neuron metabolism

Vandoorne, T., Veys, K., Guo, W., Sicart, A., Vints, K., Swijsen, A., Moisse, M., Eelen, G., Gounko, N. V., Fumagalli, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12099-4 · Cited by 59 · see citing works

The sense of antisense therapies in ALS

Daele, S. H. V., Masrori, P., Damme, P. V., & Bosch, L. V. D. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.003 · Cited by 58 · see citing works

Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers

Ma, J., Trinh, R. T. P., Mahant, I., Peng, B., Matthias, P., Heijnen, C. J., & Kavelaars, A. (2019) · Pain · doi:10.1097/j.pain.0000000000001667 · Cited by 57 · see citing works

Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models

Kuta, R., Larochelle, N., Fernandez, M., Pal, A., Minotti, S., Tibshirani, M., Louis, K. S., Gentil, B. J., Nalbantoglu, J. N., Hermann, A., et al. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01064-1 · Cited by 57 · see citing works

Distinct roles of α‐ and β‐tubulin polyglutamylation in controlling axonal transport and in neurodegeneration

Bodakuntla, S., Yuan, X., Genova, M., Gadadhar, S., Leboucher, S., Birling, M., Klein, D., Martini, R., Janke, C., & Magiera, M. M. (2021) · The EMBO Journal · doi:10.15252/embj.2021108498 · Cited by 56 · see citing works

Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6

Osko, J. D., Porter, N. J., Poli, A. N. R., Xiao, Y., Rokka, J., Jung, M., Hooker, J. M., Salvino, J. M., & Christianson, D. W. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01540 · Cited by 56 · see citing works

The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications

Guo, W., Vandoorne, T., Steyaert, J., Staats, K. A., & Bosch, L. V. D. (2020) · Brain · doi:10.1093/brain/awaa022 · Cited by 56 · see citing works

A directional 3D neurite outgrowth model for studying motor axon biology and disease

Spijkers, X. M., Pasteuning-Vuhman, S., Dorleijn, J. C., Vulto, P., Wevers, N. R., & Pasterkamp, R. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-81335-z · Cited by 55 · see citing works

Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations

Bursch, F., Kalmbach, N., Naujock, M., Staege, S., Eggenschwiler, R., Abo-Rady, M., Japtok, J., Guo, W., Hensel, N., Reinhardt, P., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz107 · Cited by 54 · see citing works

Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury

Zheng, Z., Zhou, Y., Ye, L., Lu, Q., Zhang, K., Zhang, J., Xie, L., Wu, Y., Xu, K., Zhang, H., et al. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113138 · Cited by 53 · see citing works

Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors

Tavares, M. T., Kozikowski, A. P., & Shen, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112887 · Cited by 52 · see citing works

RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights

Rummens, J., & Cruz, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00851-y · Cited by 61 · see citing works

Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis

Burg, T., Rossaert, E., Moisse, M., Van Damme, P., & Van Den Bosch, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011224 · Cited by 50 · see citing works

Histone deacetylase-6 modulates Tau function in Alzheimer's disease

Qureshi, T., & Chinnathambi, S. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119275 · Cited by 49 · see citing works

The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research

Gentile, F., Scarlino, S., Falzone, Y., Lunetta, C., Tremolizzo, L., Quattrini, A., & Riva, N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00601 · Cited by 49 · see citing works

Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation

Osseni, A., Ravel‐Chapuis, A., Belotti, E., Scionti, I., Gangloff, Y., Moncollin, V., Mazelin, L., Mounier, R., Leblanc, P., Jasmin, B. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34831-3 · Cited by 50 · see citing works

Widespread lateral gene transfer among grasses

Hibdige, S. G. S., Raimondeau, P., Christin, P., & Dunning, L. T. (2021) · New Phytologist · doi:10.1111/nph.17328 · Cited by 48 · see citing works

SOX9-induced Generation of Functional Astrocytes Supporting Neuronal Maturation in an All-human System

Neyrinck, K., Daele, J. V. D., Vervliet, T., Smedt, J. D., Wierda, K. D. B., Nijs, M., Vanbokhoven, T., D’hondt, A., Planque, M., Fendt, S., et al. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10179-x · Cited by 46 · see citing works

LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophyPreprint

Nichterwitz, S., Nijssen, J., Storvall, H., Schweingruber, C., Comley, L. H., Allodi, I., van der Lee, M., Deng, Q., Sandberg, R., & Hedlund, E. (2020) · Genome Research · doi:10.1101/gr.265017.120 · Cited by 48 · see citing works

BAG3 Pro209 mutants associated with myopathy and neuropathy relocate chaperones of the CASA-complex to aggresomes

Adriaenssens, E., Tedesco, B., Mediani, L., Asselbergh, B., Crippa, V., Antoniani, F., Carra, S., Poletti, A., & Timmerman, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-65664-z · Cited by 47 · see citing works

HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT

Rossaert, E., & Bosch, L. V. D. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146692 · Cited by 46 · see citing works

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease

Cuadrado‐Tejedor, M., Pérez-González, M., García‐Muñoz, C., Muruzabal, D., García, C., Rabal, O., Segura, V., Sánchez-Arias, J. A., Oyarzábal, J., & García‐Osta, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00149 · Cited by 45 · see citing works

Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis

Guo, W., & Bosch, L. V. D. (2018) · Cell Stress · doi:10.15698/cst2018.01.120 · Cited by 15 · see citing works

Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition

Dittlau, K. S., Krasnow, E. N., Fumagalli, L., Vandoorne, T., Baatsen, P., Kerstens, A., Giacomazzi, G., Pavie, B., Rossaert, E., Beckers, J., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.029 · Cited by 85 · see citing works

Methylation and Expression of Mutant FUS in Motor Neurons Differentiated From Induced Pluripotent Stem Cells From ALS Patients

Härtung, T., Rhein, M., Kalmbach, N., Thau‐Habermann, N., Naujock, M., Müschen, L. H., Frieling, H., Sterneckert, J. L., Hermann, A., Wegner, F., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.774751 · Cited by 14 · see citing works

Genetic Engineering of Induced Pluripotent Stem Cells and Reprogramming to Motor Neurons to Elucidate Selective Motor Neuron Death in Amyotrophic Lateral Sclerosis

Ruepp, M. (2014) · BORIS (University Library Bern)

Ontrafelen van de mechanismen verantwoordelijk voor de therapeutische effecten van HDAC6-inhibitie in amyotrofische laterale sclerose

Strubbe, D. (2026) · Lirias (KU Leuven)